Publication | Open Access
Enzyme-linked immunosorbent assay for serum amyloid A apolipoprotein with use of specific antibodies against synthetic peptides.
13
Citations
0
References
1988
Year
Immunocytochemical TechniqueImmunologyPathologySynthetic PeptidesPeptide ScienceAlzheimer's DiseaseBioanalysisImmunochemistryProtein MisfoldingAntibody EngineeringClinical ChemistryEnzyme-linked Immunosorbent AssayApo SaaHuman SerumBiochemistrySpecific AntibodiesAntibody ScreeningPharmacologyBiomolecular EngineeringNatural SciencesProtein EngineeringAmyloid A ApolipoproteinMedicine
We describe a noncompetitive enzyme-linked immunosorbent assay for amyloid A apolipoprotein in human serum (apo SAA) in which specific antibodies against synthetic peptides are used. Microtiter plates were used as solid phase and coated with affinity-purified antibodies raised against SAA1-(95-104) peptide. After incubation with delipidated plasmas, the bound apo SAA was revealed by labeled antibodies raised against SAA1-(58-69) peptide. The assay offers several advantages over existing techniques: sensitivity, specificity, simplicity, and non-use of radioisotopes. Results correlate well with those by a nephelometric method in which polyclonal antibodies are used.